Notably, the EGFR and IL13Ra2 glioma markers were clearly detected after neuronal conversion at 20 days after Neurog2 infection (Supplementary Figure S10A–S10D)42–44, suggesting that the newly converted neurons may still have retained characteristics of GBM cells, at least for the early time period after conversion. The gene discussed is IL13RA2; the disease is central nervous system cancer.